Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Civamide Nasal Spray for Trigeminal Postherpetic Neuralgia
NCT01886313Phase 2Terminated
- Sponsor
- Winston Laboratories, Inc.
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of civamide in postherpetic neuralgia (PHN), sponsored by Winston Laboratories, Inc.. Started Mar 2014; status: terminated.
02
Drugs
civamide
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01886313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01886313.